Vincenzo Montesarchio

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Pembrolizumab Versus Paclitaxel, Gastrointestinal Oncology, Medicine +7

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis

Giuseppe Di Lorenzo, Riccardo Autorino, Gianni Bruni et al. · Annals of Oncology · 2009 · 204 citations · Full text

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study

Michael Bitzer, Marius Horger, Edoardo G. Giannini et al. · Journal of Hepatology · 2016 · 134 citations

Shelter Study, Oncology, Hepatology +8

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial

Fortunato Ciardiello, Nicola Normanno, Evaristo Maiello et al. · Annals of Oncology · 2014 · 116 citations · Full text

Translational Medicine, Oncology, Gene Mutation Status +11

Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey

Alice Indini, C. Aschele, Luigi Cavanna et al. · European Journal of Cancer · 2020 · 103 citations · Full text